CRP and COVID-19: Clinicians have been using inflammatory markers such as C‐reactive protein (CRP), lactate dehydrogenase, ferritin, and interleukin (IL) levels to assess disease severity, predict outcomes, and guide therapy in critically ill COVID‐19 patients.